PledPharma AB
Pharmaceuticals - Stockholm, Stockholm County, Sweden
PledPharma AB Employees
PledPharma AB Details
PledPharma develops new drugs that protect the body against oxidative stress – a potentially debilitating and sometimes life-threatening condition that can be caused by chemotherapy treatment and following acetaminophen (paracetamol) overdose. The company's most advanced project PledOx® reduces nerve damage associated with chemotherapy. A phase IIb study has been conducted and will serve as the basis for the continued phase III development. The drug candidate Aladote® is being developed to reduce the risk of acute liver failure associated with acetaminophen poisoning. PledPharma (STO: PLED) is listed on Nasdaq First North
PledPharma AB Technologies
Email Providers
Outlook
Other
Microsoft Office 365